Produse farmaceutice
Information about customer
Title
CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE
IDNO
1016601000212
Address
MOLDOVA,
locality,
MD-2009, Republica Moldova, Chişinău str. Cosmescu 3,
MD-2009
The contact person
Macari Doina,
doina.macari@capcs.md
Purchase data
ID
ocds-b3wdp1-MD-1667486045289
Title
Produse farmaceutice
Note
CPV Code
33600000-6 - Produse farmaceutice
Rationale
List of funding sources
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1667486046094
IBAN
MD75TRPCCC518430C01859AA
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1667821929150
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1667486046266
IBAN
MD75TRPCCC518430C01859AA
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1667486046224
IBAN
MD75TRPCCC518430C01859AA
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1667486046065
IBAN
MD75TRPCCC518430C01859AA
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1667821929326
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1667821929500
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1667821928977
IBAN
MD75TRPCCC518430C01859AA
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1667821929681
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1668171666092
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1668171666664
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1668171666526
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1668171665891
IBAN
MD75TRPCCC518430C01859AA
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1668171666304
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525810769
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525810360
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525811355
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525809106
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525809703
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525810550
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525808905
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525809916
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525808555
IBAN
MD75TRPCCC518430C01859AA
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525809302
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525810139
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525808711
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525809504
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525810953
IBAN
None
Funding source cost
1718494.42 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1667486045289-FS-1670525811167
IBAN
None
Status Planning
Start the procedure:
1 Jan 2023
1 Jan 2024
Date of publication: 3 Nov 2022 16:34
Date of last modifications: 20 Dec 2022 18:39